TheraRadar
← Back
Data updated: Mar 29, 2026

WOCKHARDT BIO AG

Infectious DiseaseOncologyCardiovascular
Generics

WOCKHARDT BIO AG is a generic drug manufacturer focused on Infectious Disease, Oncology, Cardiovascular.

1984
Since
24
Drugs
-
Trials
179
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

KETOROLAC TROMETHAMINE 2026-01-22
Labeling
LOPERAMIDE HYDROCHLORIDE 2025-12-29
DECITABINE 2025-12-19
ACETAMINOPHEN 2025-12-05
CLOBETASOL PROPIONATE 2025-11-20
ONDANSETRON HYDROCHLORIDE 2025-11-18
Labeling
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE 2025-11-18
Labeling
ONDANSETRON HYDROCHLORIDE 2025-11-17
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 45%
1 drugs Phase 3: 2 Phase 2: 1 Phase 1: 2
Oncology 30%
2 drugs
Cardiovascular 15%
1 drugs
Dermatology 10%
0 drugs Phase 3: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology, Cardiovascular
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular